Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-037125
Filing Date
2023-03-27
Accepted
2023-03-27 16:15:40
Documents
2
Period of Report
2023-03-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2310588-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2310588-3_3seq1.xml 3 1567
2 POWER OF ATTORNEY tm2310588d3_ex24.htm EX-24 8740
  Complete submission text file 0001104659-23-037125.txt   11920
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Sohn Catherine A. (Reporting) CIK: 0001555132 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 23764704